A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers
about
Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonizationTranscriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence.UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumorGON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line.Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108]Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.Clinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations.1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes.Drug sensitivity in cancer cell lines is not tissue-specificAn Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis SuppressionNew Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.
P2860
Q30416020-B1A5E233-D676-4723-B9B7-3EAB4D2A84A3Q30416201-DDC75E22-1CA8-470B-A035-18725B806B73Q33922437-8C77631F-BD43-4D35-8D9E-7F6482ADD3D7Q34127978-1C8C5E59-95D1-45C9-AAE4-303AFDEFDB30Q36054919-9876C072-165A-4D60-8933-E6013D56C601Q36063561-B8C3B1E5-4D8A-4601-B824-65E21F11844AQ36236479-5148034B-EAFE-43C8-8479-CD96C4814B3DQ36522049-93838AF1-85C2-41E8-9550-9AC89FE44B2AQ37314818-1E0313B6-0088-4696-83C2-DF35B1FE15DCQ37589142-9860AAEE-8EC1-487E-A298-2914111B3472Q38081954-B42E4FEB-1723-4407-B747-A15566351349Q38886295-B8E3E5CF-F585-4140-BAEC-D93DB7A610DEQ39424176-60A33260-0412-4633-98D2-2D694BF4CBA6Q40406145-0E20282E-3A5B-4FA0-89CE-5DEDBF8B3A6F
P2860
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A framework to select clinical ...... ity with primary human cancers
@ast
A framework to select clinical ...... ity with primary human cancers
@en
type
label
A framework to select clinical ...... ity with primary human cancers
@ast
A framework to select clinical ...... ity with primary human cancers
@en
prefLabel
A framework to select clinical ...... ity with primary human cancers
@ast
A framework to select clinical ...... ity with primary human cancers
@en
P2093
P2860
P1433
P1476
A framework to select clinical ...... ity with primary human cancers
@en
P2093
Charles R Owens
Dan Theodorescu
Garrett M Dancik
Yuanbin Ru
P2860
P304
P356
10.1158/0008-5472.CAN-11-2427
P407
P577
2011-10-19T00:00:00Z